Lundbeckfonden

Lundbeckfonden is an independent non-profit private foundation located in Copenhagen, Denmark, established in 1954 by Grete Lundbeck. Its primary objective is to maintain and expand the activities of the Lundbeck Group while providing financial support for research in biomedical and natural sciences. The foundation operates under the supervision of the Danish Civil Affairs Agency and has its assets managed by a board of directors. Lundbeckfonden also oversees Lundbeckfond Ventures, an evergreen life science venture fund founded in 2009, which invests up to €50 million annually. This fund operates independently from the Lundbeck Foundation's controlling interests in various companies, focusing on generating returns to support the foundation's broader activities.

Mette Kirstine Agger

Managing Partner

Casper Breum

Partner

Kevin Dalgaard Ph.D

Principal, Lundbeckfonden BioCapital

Past deals in Denmark

Kvantify

Seed Round in 2024

Kvantify, founded in 2022 and headquartered in Copenhagen, Denmark, specializes in quantum computing management software aimed at addressing complex computational challenges across various sectors, including life sciences, financial services, and logistics. The company's platform focuses on enhancing drug discovery processes by employing proprietary physics-based methods to improve the quality of compounds tested in laboratories. By providing advanced computational drug technology, Kvantify enables life sciences companies to accelerate small molecule research and obtain actionable results that significantly impact their operations.

Snipr Biome

Series A in 2019

Snipr Biome ApS is a biotechnology company based in Copenhagen, Denmark, focusing on the development of CRISPR technology for the treatment of microbial diseases. Established in 2017, the company aims to revolutionize how such diseases are addressed by leveraging the adaptive immune system to create medicines that selectively target and eliminate harmful bacteria based on their specific DNA sequences. By utilizing a novel approach that subverts elements of the endogenous bacterial CRISPR machinery, Snipr Biome provides health professionals with innovative tools for targeted microbiome engineering, enhancing the precision and effectiveness of treatments for bacterial infections.

Asante Solutions

Series B in 2010

Asante Solutions is a Danish company founded over a decade ago, specializing in the development of medical devices aimed at improving diabetes management. With support from European venture capitalists, the company focused on creating innovative solutions for insulin delivery. Their flagship product, the Pearl Insulin Pump, features a system that utilizes pre-filled insulin cartridges, providing diabetic patients with a modern and efficient method for insulin administration. Through its advancements, Asante Solutions aims to simplify the daily management of diabetes for patients, enhancing their quality of life.

Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.